Ulrike Protzer
Ulrike Protzer | |
---|---|
Born | November 2, 1962 |
Alma mater | University of Erlangen |
Scientific career | |
Fields | Virology |
Institutions | Technical University of Munich |
![](http://upload.wikimedia.org/wikipedia/commons/thumb/6/6a/2022-03-08_Ulrike_Protzer-2211.jpg/220px-2022-03-08_Ulrike_Protzer-2211.jpg)
Ulrike Protzer is a German virologist who has been a professor at the Chair of Virology at the Technical University of Munich (TUM) since 2007. Her primary field of study is virus-host interactions of the hepatitis B virus and her work is focused on developing new therapeutic approaches for the treatment of chronic hepatitis B infection and related secondary diseases. Since the beginning of the COVID-19 pandemic, the novel virus SARS-CoV-2 has also been one of her research areas, and she has been a prominent voice in German media on this topic.
Life and career
[edit]Protzer was born on 2 November 1962.[1] She studied medicine at the University of Erlangen from 1982 until 1988, where her thesis was on the topic of postoperative nausea,[2] before qualifying as a specialist in Internal medicine in 1996. After this, she did a postdoctoral fellowship at Heidelberg University, where she studied Hepatitis B infection[3] before becoming a group leader in the Institute of Virology there in 2000. In 2002, she become an Assistant Professor in Molecular Infectiology at the University of Cologne. In 2005, she qualified as a specialist in Medical Microbiology and Virology. At the end of 2007, as part of a dual appointment, she became director of the Institute for Virology at the Technical University of Munich and the Helmholtz Centre Munich, which she has headed ever since.[1] The work of her research group focuses on Hepatitis B virus[4]
Protzer is a member of numerous professional societies. She has been Deputy Chairwoman of the Board of Directors at the German Center for Infection Research (DZIF) since 2011.,[5] and is also on the board of the German Liver Foundation,[6] and of the University Hospital Cologne.[7] She has been a member of the organising committee of the International Meeting on Hepatitis B Viruses (HBV Meeting) since 2006 [8][1]
Since the beginning of the COVID-19 pandemic, she and her working group have also been researching SARS-CoV-2[9] and she has been a prominent voice in the media as an expert in this field. She was also appointed to the Bavarian Council of Experts on the Corona Crisis[10]
Protzer is married and has two children.[1]
Honours and awards
[edit]- 2020 Heinz Maier-Leibnitz Medal[11]
- 2021 DZIF Prize for Translational Infection Research[12]
- 2022 Bavarian Order of Merit[13]
Selected publications
[edit]- Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA, Science (2014)[14]
- Living in the liver: hepatic infections, Nature Reviews Immunology (2012)[15]
- Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes, Cancer Cell (2014)[16]
- Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection, Journal of Hepatology (2011)[17]
- Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series, The Lancet Infectious Diseases (2020)[18]
- Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV, Nature (2021)
References
[edit]- ^ a b c d "Ulrike Protzer". web.med.tum.de. Retrieved 2022-12-09.
- ^ Protzer-Knolle, Ulrike. Postoperative Übelkeit: Häufigkeit und Ursachen (Thesis).
- ^ Protzer-Knolle, Ulrike (2000). Virus-Wirt-Interaktion bei der Hepatitis-B-Virus-Infektion: vom verbesserten Verständnis zur Entwicklung neuer Therapien. Heidelberg, Univ., Habil.-Schrift, 2000.
- ^ "Chronic viral hepatitis - Helmholtz Munich". www.helmholtz-munich.de. Retrieved 2022-12-09.
- ^ Rundfunk, Bayerischer (2021-05-01). "Prof. Dr. Ulrike Protzer: Die wundersame Welt der Viren" (in German).
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ "Committees". www.german-liverfoundation.com. Retrieved 2022-12-09.
- ^ "Aufsichtsrat". www.uk-koeln.de. Retrieved 2022-12-09.
- ^ "Past Meeting Organizers » International HBV Meeting". www.hbvmeeting.org. Retrieved 2022-12-09.
- ^ "COVID-19: Breakthrough Infection Can Substitute for a Third Vaccine Shot". www.helmholtz-munich.de. February 2022. Retrieved 2022-12-09.
- ^ "Prof. Protzer joins expert council on Corona crisis". www.tum.de. 31 March 2020. Retrieved 2022-12-09.
- ^ "Heinz Maier-Leibnitz Medal - TUM". www.tum.de. Retrieved 2022-12-09.
- ^ "Ulrike Protzer is awarded the DZIF Prize for Translational Infection Research | German Center for Infection Research". www.dzif.de. Retrieved 2022-12-09.
- ^ "Bavaria's highest award for three Munich scientists for their efforts during the pandemic". BioM. 23 March 2022. Retrieved 2022-12-09.
- ^ Lucifora, Julie; Xia, Yuchen; Reisinger, Florian; Zhang, Ke; Stadler, Daniela; Cheng, Xiaoming; Sprinzl, Martin F.; Koppensteiner, Herwig; Makowska, Zuzanna; Volz, Tassilo; Remouchamps, Caroline; Chou, Wen-Min; Thasler, Wolfgang E.; Hüser, Norbert; Durantel, David (2014-03-14). "Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA". Science. 343 (6176): 1221–1228. Bibcode:2014Sci...343.1221L. doi:10.1126/science.1243462. ISSN 0036-8075. PMC 6309542. PMID 24557838.
- ^ Protzer, Ulrike; Maini, Mala K.; Knolle, Percy A. (March 2012). "Living in the liver: hepatic infections". Nature Reviews Immunology. 12 (3): 201–213. doi:10.1038/nri3169. ISSN 1474-1741. PMID 22362353. S2CID 21848420.
- ^ Wolf, Monika Julia; Adili, Arlind; Piotrowitz, Kira; Abdullah, Zeinab; Boege, Yannick; Stemmer, Kerstin; Ringelhan, Marc; Simonavicius, Nicole; Egger, Michèle; Wohlleber, Dirk; Lorentzen, Anna; Einer, Claudia; Schulz, Sabine; Clavel, Thomas; Protzer, Ulrike (2014-10-13). "Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes". Cancer Cell. 26 (4): 549–564. doi:10.1016/j.ccell.2014.09.003. ISSN 1535-6108. PMID 25314080.
- ^ Lucifora, Julie; Arzberger, Silke; Durantel, David; Belloni, Laura; Strubin, Michel; Levrero, Massimo; Zoulim, Fabien; Hantz, Olivier; Protzer, Ulrike (2011-11-01). "Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection". Journal of Hepatology. 55 (5): 996–1003. doi:10.1016/j.jhep.2011.02.015. ISSN 0168-8278. PMID 21376091.
- ^ Böhmer, Merle M; Buchholz, Udo; Corman, Victor M; Hoch, Martin; Katz, Katharina; Marosevic, Durdica V; Böhm, Stefanie; Woudenberg, Tom; Ackermann, Nikolaus; Konrad, Regina; Eberle, Ute; Treis, Bianca; Dangel, Alexandra; Bengs, Katja; Fingerle, Volker (2020-08-01). "Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series". The Lancet Infectious Diseases. 20 (8): 920–928. doi:10.1016/S1473-3099(20)30314-5. ISSN 1473-3099. PMC 7228725. PMID 32422201.
This article needs additional or more specific categories. (April 2023) |